Antabuse: medication in exchange for a limited freedom--is it legal?
Recidivism among alcohol offenders--drunken drivers in particular--has led courts to experiment with programs that attempt to rehabilitate problem drinkers. One such program, in El Cajon, California, offers defendants the choice of going to jail or of submitting to a year of treatment with Antabuse, a potent drug that reacts with alcohol to produce intensely painful physical symptoms. In addition, Antabuse subjects the recipient to the risk of toxic side effects. According to the authors, the El Cajon program fails to inform defendants of the full risks and effects of Antabuse. Further, the authors maintain that the program uses the threat of a jail sentence to coerce defendants into consenting to Antabuse therapy. The authors conclude that defendants' consent is so tained by these factors that the program amounts to involuntary treatment. Consequently, the authors suggest that the El Cajon program violates defendants' constitutional right to privacy. Finally, the severity of the Antabuse-alcohol reaction leads the authors to contend that the program constitutes cruel and unusual punishment.
D000056:Accident Prevention; D000063:Accidents, Traffic; D000437:Alcoholism / Q000517:prevention & control*; D002140:California; D002961:Civil Rights / Q000331:legislation & jurisprudence*; D003068:Coercion; D030881:Disclosure; D004221:Disulfiram / Q000627:therapeutic use*; D006801:Humans; D035846:Law Enforcement; D037141:Mandatory Programs; D011678:Punishment; D012008:Recurrence; D018570:Risk Assessment
D004221:Disulfiram